Skip to main content

Table 1 Sociodemographic and clinical characteristics by antiretroviral therapy (ART) status among DC Cohort participants at study enrollment, including comparisons within ART status by insurance type in Washington, DC, 2011–2015

From: Despite early Medicaid expansion, decreased durable virologic suppression among publicly insured people with HIV in Washington, DC: a retrospective analysis

 

ART-experienced

ART-naïve

 

ART-experienced

Only2

ART-naïve

Only3

N (%)

3723 (95.3)

N (%)

185 (4.7)

 

Public vs Private

Public vs Private

Characteristic

Total N (%)

Public

Private

Public

Private

P-value1

P-value

P-value

 

3908

2537(68.1)

1186(31.9)

115(62.2)

70(37.8)

0.089

  

Age

 Mean

46.3

47.3

45.3

40.0

39.2

<.0001

<.0001

0.693

 IQR

38.0–55.0

40.0–56.0

38.0–53.0

26.0–53.0

31.0–46.0

   

Years since HIV diagnosis4

 Mean

13.3

13.4

14.0

7.3

5.9

<.0001

0.696

0.043

 IQR

6.4–19.1

6.3–19.1

7.9–20.1

2.5–8.1

1.6–7.0

   

Sex at birth

 Female

1190(30.4)

918(36.2)

227(19.1)

37(32.2)

8(11.4)

0.064

<.0001

0.001

 Male

2718(69.6)

1619(63.8)

959(80.9)

78(67.8)

62(88.6)

   

Race/Ethnicity

 Hispanic

198(4.8)

115(4.5)

61(5.1)

4(3.5)

9(12.9)

0.420

<.0001

<.0001

 NH Black

3025(77.4)

2204(86.7)

678(57.2)

107(93.0)

36(51.4)

   

 NH White

538(13.8)

160(6.3)

354(29.9)

2(1.7)

22(31.4)

   

Other/Unknown

156(4.0)

58(2.3)

93(7.8)

2(1.7)

3(4.3)

   

Housing

 Permanent

3226 (82.6)

1959(77.2)

1125(94.9)

78(67.8)

64(91.4)

0.076

<.0001

0.001

 Temporary

272(7.0)

245(9.7)

12(1.0)

14(12.2)

1(1.4)

   

 Other/Unknown

410(10.5)

333(13.1)

49(4.1)

23(20.0)

5(7.1)

   

Employment

 Employed

1220(31.2)

336(13.2)

812(68.5)

23(20.0)

49(70.0)

0.076

<.0001

<.0001

 Unemployed

1248(31.9)

1119(44.1)

76(6.4)

42(36.5)

3(4.3)

   

 Other/Unknown

1440(36.9)

1082(42.6)

298(25.1)

50(43.5)

18(25.7)

   

HIV Risk

 MSM

1467(37.5)

716(28.2)

664(56.0)

39(33.9)

48(68.6)

0.027

<.0001

<.0001

 IDU

242(6.2)

196(7.7)

33(2.8)

10(8.7)

3(4.3)

   

 Heterosexual

1325(33.9)

981(38.7)

289(24.4)

46(40.0)

9(12.3)

   

 Other/Unknown5

874(22.4)

644(25.4)

200(16.9)

20(17.4)

10(14.3)

   

History of AIDS

1424(36.4)

938(36.9)

459(38.7)

13(11.3)

14(20.0)

<.0001

0.309

0.130

Clinic site

 Hospital

1608(41.2)

601(23.7)

912(76.9)

42(36.5)

53(75.7)

0.005

<.0001

0.001

 Community

2300(58.9)

1936(76.3)

274 23.1)

73(63.5)

17(24.3)

   

Comorbidities6

 Drug abuse

625(16.0)

539(21.3)

58(4.9)

23(20.0)

5(7.1)

0.837

<.0001

0.020

 Depression

770(19.7)

542(21.4)

198(16.7)

22(19.1)

8(11.4)

0.256

0.001

0.218

 Psychoses

101(2.6)

98(3.9)

1(0.1)

2(1.7)

0(0)

0.238

<.0001

0.527

 Hypertension

1261(32.3)

903(35.6)

311(26.2)

33(28.7)

14(20.0)

0.044

<.0001

0.224

 Hepatitis C

519(13.3)

415(16.4)

80(6.8)

19(16.5)

5(7.1)

1.000

<.0001

0.074

  1. Note: P-values computed using χ2 test for categorical variables and 2-sample t-test for continuous variables; P-values in bold denote statistical significance at the 0.05 level. ART = antiretroviral therapy. IQR = interquartile range; MSM = men who have sex with men. VL = Viral Load
  2. 1P-values refer to the χ2 or t-test between the ART-experienced and ART-naïve groups
  3. 2A total of 104 ART-experienced participants were excluded due to other/unknown insurance status
  4. 3A total of 11 ART-naive participants were excluded due to other/unknown insurance status4Year since HIV diagnosis computed as of June 30, 2015
  5. 5Other/unknown HIV risk defined as the sum of Blood Transfusion, Coagulation Disorder, Other, Perinatal, and Unknown categories
  6. 6Selected comorbidities based on top 5 most common conditions in the DC Cohort at study enrollment based on ICD-9/10 diagnosis data